The purpose of this study was to comprehensively examine cardiovascular reserve function with exercise in patients with heart failure and preserved ejection fraction (HFpEF).
Mean BP (diastolic pressure plus pulse pressure divided by 3) and end-systolic BP (0.9 ϫ systolic BP) were calculated as previously described (6) . Exercise metabolic performance. Subjects underwent maximal-effort upright cycle exercise testing starting at 20 W workload, increasing by 20 W every 3 min until exhaustion. Oxygen consumed (VO 2 ), carbon dioxide produced (VCO 2 ), minute ventilation (V E ), and respiratory exchange ratio (RER ϭ VCO 2 /VO 2 ) were measured (MedGraphics, St. Paul, Minnesota) throughout exercise to quantify exercise performance (5) . Subjective symptoms of fatigue and dyspnea were recorded at each workload by the Borg effort score (6 to 20) and dyspnea score (0 to 10), where higher values indicate more severe symptoms (7) . Cardiovascular function and reserve analysis. EchoDoppler measurements represent the mean of Ն3 beats. The left ventricular (LV) mass was obtained from 2-dimensional measurements of wall thickness and chamber dimension (8) . The EF was determined from Simpson's biplane method (8) . Stroke volume (SV) was determined from the LV outflow dimension and pulse-wave Doppler and was indexed to body surface area (SVI). Cardiac index was determined from the product of heart rate (HR) and SVI.
CHRONOTROPIC RESERVE. Heart rate reserve (HRR) was determined from continuous 12-lead electrocardiogram using standard formulas, with chronotropic incompetence is defined as HRR Ͻ0.8, or HRR Ͻ0.62 in subjects receiving beta-adrenergic antagonists (9) .
PRE-LOAD AND PRE-LOAD RESERVE.
The left ventricular end-diastolic volume index (LVEDVI) was determined from the quotient of SVI/EF (8, 10) . Resting transmitral flow velocities (E and A) and mitral annular tissue-Doppler velocities (E= and A=) were measured to assess diastolic function. The E/E= ratio was used to estimate filling pressures at rest (8) . Doppler estimation of filling pressures with exercise was not performed.
CONTRACTILE FUNCTION AND RESERVE. Load-independent contractility was determined using 3 separate indexes: 1) peak power index (PWRI [determined from product of peak volumetric ejection rate from LV outflow Doppler and systolic BP, divided by EDV]) (10, 11) ; 2) single-beat end-systolic elastance (Ees [determined from BP, SV, EF, and pre-ejection and systolic ejection time intervals from LV outflow Doppler]) (12) ; and 3) single-beat pre-load recruitable stroke work (PRSW [determined from SV, mean BP, LV mass, and EDV]) (13) . The change in each parameter was used to characterize contractile reserve. (6, 8) at rest, with the change in each during exercise used to characterize global arterial reserve.
ENDOTHELIAL FUNCTION. The PAT was measured using the EndoPAT 2000 system (Itamar-Medical, Caesarea, Israel). Endothelial function was quantified by the reactive hyperemic (RH) change in digital blood flow after arm occlusion (14, 15) . After 5 min of baseline recording, a BP cuff was inflated to supra-systolic pressure in the test arm. After 5 min of occlusion, the cuff was rapidly deflated, with PAT tracings recorded. The RH-PAT response was determined as the ratio of PAT amplitude in the test arm to control arm, averaged in 30-s intervals after cuff deflation, divided by the average PAT ratio measured for the 140-s interval before cuff inflation. The reactive hyperemia index (RHI) was determined as the RH-PAT ratio measured between 60 s and 120 s after occlusion. Endothelial dysfunction was defined categorically by RHI Ͻ2.0. The RHI was log-transformed for subsequent analysis (14) .
Dynamic peripheral vasodilation was further assessed by changes in PAT amplitude responses during exercise (16) . Mean PAT amplitudes were determined from 3 min recordings obtained at rest and at peak exercise after manually deleting motion artifacts. Exercise PAT responses were normalized to baseline PAT amplitude to create a dimensionless unit, and represent the average of both arms.
VENTRICULAR-VASCULAR COUPLING AND COUPLING
RESERVE. Ventricular-arterial interaction was assessed by the coupling ratio (Ea/Ees) of arterial to ventricular systolic elastance (6) . Statistical analysis. Continuous variables are reported as mean Ϯ SD. Between-group differences were compared by chi square, 1-way analysis of variance, or Wilcoxon rank-sum/Kruskal-Wallis tests. Normality was evaluated by the Shapiro-Wilk W test. Bonferroni correction was applied for multiple comparisons. The hyperemic changes in PAT amplitude between groups were compared by repeated measures analysis of variance assuming a quadratic relationship of PAT ratio over time. Linear regression was performed to test associations between reserve function, symptoms and exercise performance.
Results
Subject characteristics. Age, sex, race (all but 2 Caucasian), and renal function were similar in all groups, with controls and HFpEF being more obese than hypertensive subjects (Table 1) . Coronary disease and diabetes mellitus were more common in HFpEF subjects. The B-type natriuretic peptide levels were higher and KCCQ scores lower (more symptomatic) with HFpEF. The HFpEF subjects were more likely to be receiving loop diuretics and lipidlowering therapy. Other medication use was similar in HFpEF subjects and hypertensive subjects, including betablockers and mean dose of beta-blockers (not shown).
Resting cardiovascular function. The HR, BP, LVEDVI, contractility, ventricular-arterial coupling, and cardiac index were similar across groups at rest ( Table 1) . The E/E= was higher in HFpEF subjects, consistent with diastolic dysfunction. Global vascular function (Ea and SVRI) was not different between groups. However, the hyperemic increase in PAT amplitude after cuff occlusion was blunted in HFpEF and hypertensive subjects compared with controls, consistent with depressed endothelium-dependent vasodilation (Fig. 1) . Mean RHI was lower in HFpEF and hypertensive subjects compared with controls, but similar in HFpEF and hypertensive subjects ( Table 1 ). The prevalence of endothelial dysfunction was 42% in HFpEF subjects (p Ͻ 0.05 vs. control; p ϭ NS vs. hypertension), 28% in hypertensive subjects (p ϭ 0.056 vs. control), and 0% in controls. Exercise performance. Exercise time, peak workload, VO 2 at ventilatory threshold, peak VO 2 , and percent predicted peak VO 2 were all impaired in HFpEF subjects compared with control and hypertensive subjects, whereas the latter groups were similar ( Table 2 ). Borg effort and dyspnea scores in HFpEF were higher at matched submaximal workload (20 W), indicating greater perceived difficulty with exercise. At peak, Borg scores were similar in HFpEF subjects, hypertensive subjects, and controls, consistent with maximal subjective effort in all groups. Peak RER tended to be lower in HFpEF subjects, though excluding the subjects who failed to attain a peak RER Ͼ1.0 did not affect the differences observed in any parameters (not shown). Reserve responses at matched low-level (20 W) exercise. CHRONOTROPIC RESERVE. HR increased in HFpEF subjects (ϩ23 Ϯ 6 beats/min, p Ͻ 0.0001), hypertensive subjects (ϩ23 Ϯ 10 beats/min, p Ͻ 0.0001), and controls (ϩ26 Ϯ 8 beats/min, p Ͻ 0.0001), with no between-group difference (p Ͼ 0.2).
PRE-LOAD RESERVE. The LVEDVI increased in HFpEF subjects (ϩ6 Ϯ 9 ml/m 2 ), hypertensive subjects (ϩ5 Ϯ 7 ml/m 2 ), and controls (ϩ11 Ϯ 9 ml/m 2 ; p Ͻ 0.0001 for all), with no between-group difference (p Ͼ 0.2).
CONTRACTILE RESERVE. The increase in contractility assessed by Ees, PRSW, and PWRI was 65% to 85% lower in HFpEF subjects compared with hypertensive and normal controls (Fig. 2) . The LVESVI failed to drop in HFpEF subjects (ϩ2 Ϯ 7 ml/m 2 ) in comparison with hypertensive and healthy controls (Ϫ6 Ϯ 5 ml/m 2 and Ϫ5 Ϯ 5 ml/m 2 , respectively; both p Ͻ 0.05 compared with HFpEF subjects).
VASCULAR FUNCTION AND RESERVE. Vasodilation was attenuated in HFpEF subjects, with less reduction in SVRI and Ea compared with hypertensive and normal controls (Fig. 2) .
VENTRICULAR VASCULAR COUPLING RESERVE. The combination of blunted increases in contractility and impaired vasodilation in HFpEF patients was associated with impaired ventricular-arterial coupling, with less reduction in the Ea/Ees ratio ( Fig. 2 ) and less increase EF (ϩ0 Ϯ 8% 847 JACC Vol. 56, No. 11, 2010
Borlaug et al. September 7, 2010:845-54 Cardiovascular Reserve Dysfunction in HFpEF in HFpEF vs. ϩ14 Ϯ 7% in controls and ϩ13 Ϯ 6% in hypertensive subjects, p Ͻ 0.0001). Augmentation in cardiac index at 20W was lower in HFpEF subjects (ϩ1.1 Ϯ 0.4 l/min ϫ m 2 ) than in controls (ϩ2.2 Ϯ 0.9 l/min ϫ m 2 , p Ͻ 0.001) and hypertensive subjects (vs. ϩ1.8 Ϯ 0.7 l/min ϫ m 2 , p ϭ 0.002). Reserve responses at peak exercise. CHRONOTROPIC RESERVE. Peak HR was reduced in HFpEF subjects compared with both control and hypertensive subjects ( Table 3 ). The HRR was lower in HFpEF subjects (56 Ϯ 17%) compared with hypertensive subjects (79 Ϯ 20%, p Ͻ 0.001) and controls (93 Ϯ 17%, p Ͻ 0.0001), even after adjusting for chronic beta-blocker use. Among HFpEF subjects with peak RER Ͼ1.0, the prevalence of chronotropic incompetence was 57%.
PRE-LOAD RESERVE.
The EDVI tended to increase more in controls, but this was not significant (p ϭ 0.2).
CONTRACTILE RESERVE. Increases in contractility at peak exercise were ϳ65% lower in HFpEF subjects compared with hypertensive subjects and controls for each loadindependent measure (p Ͻ 0.001). Peak exercise reduction in ESVI was impaired in HFpEF subjects.
VASCULAR RESERVE. Exercise reduction in SVRI and augmentation in peripheral blood flow (PAT amplitude) were both blunted in HFpEF subjects compared with hypertensive subjects and controls, although the changes in Ea were similar across groups at peak. ACEI ϭ angiotensin-converting enzyme inhibitors; ARB ϭ angiotensin-receptor blockers; BNP ϭ B-type natriuretic peptide; BP ϭ blood pressure; Ea ϭ arterial elastance; Ees ϭ left ventricular end-systolic elastance; GFR ϭ glomerular filtration rate; HFpEF ϭ heart failure with preserved ejection fraction; KCCQ ϭ Kansas City Cardiomyopathy Questionnaire; LVEDVI ϭ left ventricular end-diastolic volume index; PRSW ϭ left ventricular pre-load recruitable stroke work; PWRI ϭ peak left ventricular power index; RHI ϭ reactive hyperemia index; SVRI ϭ systemic vascular resistance index. After adjusting for history of coronary disease, all differences in endothelial function and ventricular-vascular reserve remained significant (not shown). Subgroup analysis restricted to only subjects without history of coronary disease showed similar impairments in low-level and peak contractile reserve in HFpEF subjects, with the exception of the increase in Ees at 20 W, which was no longer significant (not shown). Among subjects without coronary disease, the prevalence of endothelial dysfunction was 0% in controls, 31% in HFpEF subjects, and 31% in hypertensive subjects (each p ϭ 0.02 compared with control). In this subgroup, log RHI tended to be lower in HFpEF subjects compared with control (0.96 Ϯ 0.42 vs. 1.33 Ϯ 0.34), although this difference was no longer significant (p ϭ 0.09 after Bonferroni). Global reserve dysfunction and exercise intolerance in HFpEF. Several indexes of cardiovascular reserve function including chronotropic (⌬HR), contractile (⌬PWRI), vascular (⌬SVRI, ⌬PAT), endothelial (log RHI), and ventricular-arterial (⌬Ea/Ees) coupling responses were each significantly associated with peak VO 2 ( Table 4 ). The number of individual reserve abnormalities (defined as Ͻ25th percentile values observed in the healthy controls) were tabulated for each subject. The HFpEF patients had the greatest number of abnormalities (Fig. 3A) , and the presence of more reserve abnormalities was associated with Exercise Performance progressively more depressed exercise capacity (Fig. 3B ). Of note, several indices of cardiovascular reserve function also correlated with subjective dyspnea and fatigue at matched low-level workload (Table 4) .
Clinical Characteristics and Resting Cardiovascular Function

Discussion
This study found evidence for global impairment in cardiovascular reserve function in HFpEF subjects compared with normal and hypertensive controls, including limitations in chronotropic, contractile, endothelial, and vascular reserve, resulting in markedly impaired ventricular-arterial coupling responses to exercise. Depressed reserve responses correlated with reduced exercise capacity and greater subjective symptoms at low-level workload, and the accumulation of more individual abnormalities was associated with progressively greater impairment in exercise capacity. These data confirm and extend upon a growing body of evidence demonstrating that the pathophysiology of HFpEF is complex and characterized by global impairment in multiple domains of cardiovascular reserve function. Contractile reserve. Patients with HFpEF have a "normal" ejection fraction, but EF is a rather poor measure of contractility because of its sensitivity to load and chamber remodeling (17, 18) . To accurately assess contractility, preload and afterload must both be accounted for (19) . Using load-independent measures, we observed that contractile reserve responses with exercise were blunted in HFpEF subjects at peak exercise. However, it is difficult to discern whether differences in peak contractility alone are meaningful, because HFpEF subjects reach lower peak workloads. In other words, are observed deficits in contractile reserve in HFpEF subjects a mechanism or consequence of exercise limitation?
The current study resolves this question by demonstrating that at matched, low-level workload (20 W), contractile reserve is impaired in HFpEF. In an earlier study, we found inotropic reserve impairments in HFpEF subjects compared with hypertensive subjects at peak but not at low-level exercise (5) . However, the hypertensive control group in the latter study had more severe limitation (peak VO 2 70% predicted) and more abnormal ventricular remodeling (ϳ90% with LV hypertrophy). The current findings are consistent with recent reports from other groups showing attenuated increases in EF with exercise (20, 21) and reduced tissue-Doppler systolic shortening velocities and strain (22) .
The mechanisms limiting contractile reserve in HFpEF remain speculative. While 1 prior study reported that resting contractility in HFpEF subjects is similar to normal subjects (19) , a recent population-based study found that chamber and myocardial contractility are subtly but significantly impaired in HFpEF subjects (18) . We speculate that these "mild" impairments in resting contractility become more limiting during the stress imposed by exercise. human HFpEF. Finally, both systolic and diastolic reserve may be affected by abnormalities in energy substrate bioavailability, as has recently been demonstrated in HFpEF (21, 24) . Endothelial function and vasodilator reserve. Investigators first noted endothelial dysfunction in patients with heart failure and reduced ejection fraction (HFrEF) in the early 1990s (25, 26) , and recent work has suggested that this may contribute to symptoms of breathlessness and fatigue by enhancing abnormal skeletal muscle signaling during exercise (27) . However, few studies have examined endothelial function in HFpEF subjects. Hundley et al. (28) measured exercise capacity and flow-mediated arterial dilation in the femoral artery by magnetic resonance imaging in 9 subjects with HFpEF, comparing them to 11 normal controls and 10 HFrEF subjects. Exercise capacity was reduced in both HFrEF and HFpEF, but flow-mediated arterial dilation was impaired only in HFrEF. However, flow-mediated vasodilation in large conduit arteries (e.g., femoral) may differ from that observed in the microvasculature (as in the current study). We now show for the first time that endothelial function is impaired in HFpEF subjects compared with apparently healthy controls, assessed at the microvasculature. Part of this deficit may be related to atherosclerosis, though RHI remained lower in HFpEF subjects after adjusting for coronary disease, and mean RHI values were similar in HFpEF patients with or without coronary disease. Hypertensive subjects also displayed endothelial dysfunction, but had preserved exercise capacity, possibly related to preservation of other components of reserve function. Endothelial dysfunction correlated with reduced exercise capacity and greater symptoms, suggesting a role in contributing to objective and subjective exertional intolerance in HFpEF.
During normal exercise, arterial resistance decreases to accommodate large increases in flow with minimal increment in pressure (6) . Prior studies have demonstrated using derived indices of arterial load, such as SVRI and Ea, that 
Final column reflects overall group ANOVA or chi square. For between-group comparisons: *p Ͻ 0.05 versus control; †p Ͻ 0.05 versus hypertension (ANOVA after Bonferroni). CI ϭ cardiac index; ⌬ ϭ peak change; EDVI ϭ end-diastolic volume index; HR ϭ heart rate; PAT ϭ peripheral arterial tonometry; other abbreviations as in Table 1 Borlaug et al. September 7, 2010:845-54 Cardiovascular Reserve Dysfunction in HFpEF exercise vasodilation is blunted in HFpEF (5, 20, 22) . The current findings confirm these studies using the same derived vascular measures, and importantly, extend upon them by demonstrating for the first time that directly measured peripheral vasodilation (change in digital PAT amplitude with exercise) is also depressed in HFpEF. Ventricular-arterial interaction with exercise. Abnormal vasorelaxation, combined with blunted contractile reserve, led to abnormal ventricular-arterial coupling in HFpEF. In the pressure-volume plane, contractility is expressed by end-systolic elastance (Ees), defined by the slope and intercept of the end systolic pressure-volume relationship, while afterload is defined by effective arterial elastance (Ea), a lumped parameter incorporating both mean and pulsatile vascular load (6) . Ventricular-arterial interaction is described by the coupling ratio (Ea/Ees). Under normal circumstances, Ea/Ees drops with exercise, because the increase in Ees exceeds the change in Ea, leading to an increase in EF (6) . The normal exercise drop in Ea/Ees becomes impaired with aging (29), and Phan et al. (21) recently found that the drop in the ratio of end-systolic volume to stroke volume (which is related to Ea/Ees) was impaired in HFpEF subjects compared with hypertensive subjects at 50% maximal effort (21) . The current findings confirm and extend upon the latter, showing that abnormal ventricular-arterial coupling is present both at matched, objective low-level workload and throughout exercise in HFpEF subjects compared with hypertensive subjects and normal controls.
Chronotropic reserve. The current data confirm previously reported impairment in peak chronotropic reserve and its relationship to exercise limitation (5, 21) . Heart rate reserve was lower in the HFpEF patients, and more than half met criteria for chronotropic incompetence (9) . In contrast to an earlier study (5) and to contractile and vascular reserves in this study, HR responses were not blunted at submaximal workload in HFpEF, making it difficult to discern whether chronotropic incompetence contributed to exercise limitation in HFpEF or was simply related to the lower peak workload achieved. Pre-load reserve. While diastolic dysfunction was present at rest, exercise changes in diastolic compliance and relaxation were not assessed in this study. Kitzman et al. (30) found that EDVI failed to increase with exercise in HFpEF patients compared with controls, whereas in the current study and in an earlier report (5), EDVI increased by 5% to 10% in HFpEF subjects during exercise. However, nearly one-half of the patients in the Kitzman study had either infiltrative or hypertropic cardiomyopathy, diseases known to produce the most extreme forms of diastolic dysfunction. These patients were excluded from the latter analyses, and that may explain the apparent discrepancies in pre-load reserve. We observed a trend toward greater EDVI reserve in healthy controls at peak exercise compared with HFpEF subjects and hypertensive subjects, and the absence of a significant difference may be related to the small sample size in the healthy controls. Finally, changes in filling pressures with exercise, which are known to be abnormal in HFpEF subjects (30, 31) , were not assessed in this study, and therefore the current results should not be interpreted as minimizing the importance of diastolic reserve in HFpEF (30) . Clinical implications. Because diastolic dysfunction is readily detectable in most HFpEF patients and plausibly explains many symptoms, it has traditionally been conceptualized as the sole or predominant mechanism. This pathophysiologic model is similar to other disorders where a single lesion (e.g., cortisol excess) produces a wide variety of clinical sequelae (bone loss, hypertension, glucose intolerance). Our data show that rather than being a disease of diastolic dysfunction alone, HFpEF is characterized by a number of abnormalities in endothelial and ventricularvascular reserve function that contribute in a coordinated Global Reserve Dysfunction (A) Heart failure with preserved ejection fraction (HFpEF) subjects displayed a greater number of abnormalities in cardiovascular reserve function than did hypertensive (HTN) subjects and normal controls (CON), and hypertensive subjects had more abnormalities than healthy controls. ‫ء‬p Ͻ 0.001; †p Ͻ 0.05. (B) The presence of a greater number of reserve abnormalities was associated with more severely depressed exercise capacity. Numbered colored bars indicate total number of subjects in each grouping for control subjects (blue), hypertensive subjects (green), and HFpEF subjects (red). The p value reflects 1-way analysis of variance (ANOVA) testing the relationship of number of abnormalities versus peak VO 2 .
fashion in patients with HFpEF. We speculate and the epidemiology studies suggest that HFpEF is not due to 1 systemic disease, but rather, in the majority of cases, represents a culmination of a number of different disease processes associated with aging, hypertension, and diabetes mellitus. Understanding the pleiotropic nature of reserve limitation of HFpEF may allow for more focused and tailored therapies for individual patients, and it is hoped that future research will identify the specific mechanistic processes that produce global reserve dysfunction in HFpEF. Study limitations. This is a cross-sectional study and cannot assess causality. Pressure and flow were not directly measured, but rather estimated from noninvasive surrogates. While these derived parameters have been validated in prior studies against invasive hemodynamic measurements (10 -13), there is inherently greater variability compared with the gold standard measures. Because of image foreshortening during exercise, EDVI was determined from SV and EF rather than from 2-dimensional imaging alone. This assumes that mitral regurgitation, which was not measured directly, was not significant.
Conclusions
Heart failure is often conceptualized as being caused by isolated, discrete disease mechanisms, such as diastolic or systolic dysfunction. However, HFpEF is a disease of the elderly, and with aging, patients acquire multiple comorbidities and processes that integrate in complex ways to produce symptoms and exercise intolerance. The current results, taken in concert with other recent studies, suggest that in most cases, HFpEF is not simply the result of a single impairment in 1 component of cardiovascular function, but rather a culmination of global limitations of cardiovascular reserve function-chronotropy, inotropy, lusitropy and vasodilation-all resulting in impaired ventricular arterial coupling, depressed cardiac output response, and subjective and objective exercise intolerance. Recognition that reserve dysfunction in HFpEF is a global process affecting many cardiovascular responses to stress will aid in the design and testing of future therapeutic strategies for HFpEF.
